Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: De La Garza_2008_Pharmacol.Biochem.Behav_89_200

Reference

Title: The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers
De La Garza R, 2nd, Mahoney JJ, 3rd, Culbertson C, Shoptaw S, Newton TF
Ref: Pharmacol Biochem Behav, 89:200, 2008 : PubMed

        



Related information



Citations formats

De La Garza R, 2nd, Mahoney JJ, 3rd, Culbertson C, Shoptaw S, Newton TF (2008)
The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers
Pharmacol Biochem Behav 89: 200-8

De La Garza R, 2nd, Mahoney JJ, 3rd, Culbertson C, Shoptaw S, Newton TF (2008)
Pharmacol Biochem Behav 89: 200-8



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer